Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  IGI LABORIGI       

End-of-day quote. End-of-day quote  - 08/13
5.99 USD   +3.63%
04/29 TELIGENT : reports 1Q loss
04/28 TELIGENT, INC. : Announces First Quarter 2016 Results
04/14 TELIGENT : To Hold Conference Call For 1st Quarter 2016 Results
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 65,0 M
EBIT 2016 1,20 M
Net income 2016 -10,5 M
Debt 2016 54,5 M
Yield 2016 -
Sales 2017 95,0 M
EBIT 2017 14,2 M
Net income 2017 0,26 M
Debt 2017 62,8 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 5,34x
EV / Sales 2017 3,74x
Capitalization 293 M
More Financials
Company
Teligent, Inc. develops, manufactures and markets topical formulations.The company sells generic topical pharmaceutical products under IGI label.It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.The company's products... 
Sector
Pharmaceuticals
Calendar
05/04 | 08:10pmPresentation
More about the company
Surperformance© ratings of IGI LABORIGI
Trading Rating : Investor Rating :
More Ratings
Latest news on IGI LABORIGI
04/29 TELIGENT : reports 1Q loss
04/28 TELIGENT, INC. : Results of Operations and Financial Condition, Financial Statem..
04/28 TELIGENT, INC. : Announces First Quarter 2016 Results
04/14 TELIGENT : To Hold Conference Call For 1st Quarter 2016 Results
03/31 TELIGENT : Change in Directors or Principal Officers, Other Events, Financial St..
03/31 TELIGENT : Appoints Dr. Carole Ben-Maimon To Board Of Directors
03/21 TELIGENT : Announces Launch Of Cefotan® (Cefotetan For Injection)
03/14 TELIGENT : To Present At Roth Capital Partners 28th Annual Growth Stock Conferen..
More news
Sector news : Pharmaceuticals - NEC
01:04a GLAXOSMITHKLINE : Director/PDMR Shareholding
01:04a GLAXOSMITHKLINE : Director/PDMR Shareholding
01:04a GLAXOSMITHKLINE : 1st Quarter Results
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Chart IGI LABORIGI
Duration : Period :
IGI LABORIGI Technical Analysis Chart | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions